|
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2011
|
|
| Segment Reporting Information [Line Items] | ||
| External sales | $ 75,025 | $ 77,596 |
| Earnings before income taxes | 37,986 | 40,500 |
|
Biotechnology
|
||
| Segment Reporting Information [Line Items] | ||
| External sales | 69,503 | 72,303 |
| Earnings before income taxes | 36,994 | 39,984 |
|
Hematology
|
||
| Segment Reporting Information [Line Items] | ||
| External sales | 5,522 | 5,293 |
| Earnings before income taxes | 2,103 | 1,918 |
|
Reportable Segment
|
||
| Segment Reporting Information [Line Items] | ||
| Earnings before income taxes | 39,097 | 41,902 |
|
Unallocated Amount to Segment
|
||
| Segment Reporting Information [Line Items] | ||
| Earnings before income taxes | $ (1,111) | $ (1,402) |